IPIX
OQB Innovation Pharmaceuticals Inc.$0.0002 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0002, and at the day’s high of $0.0002
- YTD change
- -80.00%
- vs 20-day SMA
- -57.45%
- vs 200-day SMA
- -71.15%
Price ranges
Price & Performance
-0.00 (-33.33%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $1.5050
- IPIX is down 80% since the beginning of the year
- IPIX is down 90% over the past 12 months
- IPIX is down 33% over the past 1 month
IPIX reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -90.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +100.00%
- vs 8-day SMA
- -5.88%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. The company was founded by Krishna Kumar Menon, George W. Evans, and Leo Ehrlich on June 20, 2007 and is headquartered in Wakefield, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
